Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately.
●(See "Society guideline links: Primary prevention of cardiovascular disease".)
●(See "Society guideline links: Obesity in adults".)
●(See "Society guideline links: Menopause".)
●(See "Society guideline links: Non-ST-elevation acute coronary syndromes (non-ST-elevation myocardial infarction)".)
●(See "Society guideline links: ST-elevation myocardial infarction (STEMI)".)
●(See "Society guideline links: Chronic coronary syndrome".)
●(See "Society guideline links: Occlusive carotid, aortic, renal, mesenteric, and peripheral atherosclerotic disease".)
International
●International Council of Cardiovascular Prevention and Rehabilitation (ICCPR): Guideline on women-focused cardiovascular rehabilitation (2022)
●World Health Organization (WHO): Prevention of cardiovascular disease − Guidelines for assessment and management of cardiovascular risk (2007)
Canada
●Canadian Cardiovascular Society (CCS): Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults (2021)
●CCS: Position statement on familial hypercholesterolemia, update (2018)
●Canadian Association of Cardiac Rehabilitation (CACR) and CCS: Society position statement for systemizing inpatient referral to cardiac rehabilitation 2010 (published 2011)
●CCS: Society position statement on smoking cessation and the cardiovascular specialist (2011)
United States
●American College of Cardiology (ACC): Expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk (2022)
●ACC: Expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia (2021)
●American Heart Association (AHA): A scientific statement on harnessing mobile health technology for secondary cardiovascular disease prevention in older adults (2021)
●ACC: Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes (2020)
●Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD): Clinical practice guidelines for the management of dyslipidemia for cardiovascular risk reduction (lipids) (2020)
●American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), AHA, and ACC: A scientific statement on home-based cardiac rehabilitation (2019)
●ACC: Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease (2018)
●AHA/ACC/AACVPR/American Association Academy of Physician Assistants (AAPA)/Association of Black Cardiologists (ABC)/American College of Preventive Medicine (ACPM)/American Diabetes Association (ADA)/American Geriatrics Society (AGS)/American Pharmacists Association (APhA)/American Society for Preventive Cardiology (ASPC)/National Lipid Association (NLA)/Preventive Cardiovascular Nurses Association (PCNA): Guideline on the management of blood cholesterol (2018)
●AHA: A scientific statement on meditation and cardiovascular risk reduction (2017)
●ACC/AHA: 2015 secondary prevention lipid performance measures, focused update (published 2016)
●AHA: A scientific statement for secondary prevention after coronary artery bypass graft surgery (2015)
●AHA/ACC/The Obesity Society (TOS): 2013 guideline for the management of overweight and obesity in adults (published 2014)
●ACC/AHA: Guideline on the assessment of cardiovascular risk (2013)
●AHA: Scientific statement for secondary prevention of atherosclerotic cardiovascular disease in older adults (2013)
●American Society for Nutrition (ASN): Scientific statement on consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease (2013)
Europe
●European Society of Cardiology (ESC): Guidelines on cardiovascular disease prevention in clinical practice (2021)
●ESC: Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (2020)
●European Association of Preventive Cardiology (EAPC): A position paper on exercise training for patients with type 2 diabetes and cardiovascular disease (2019)
●ESC: Guidelines on management of dyslipidaemias – Lipid modification to reduce cardiovascular risk (2019)
●ESC and the European Association for the Study of Diabetes (EASD): Guidelines on diabetes, pre-diabetes, and cardiovascular diseases (2019)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Guideline on cardiovascular disease − Risk assessment and reduction, including lipid modification (2023)
●NICE: Quality standard on cardiovascular risk assessment and lipid modification (2015, updated 2023)
●NICE: Guideline on acute coronary syndromes (2020)
●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on cardiac rehabilitation (2017)
●SIGN: A national clinical guideline on risk estimation and the prevention of cardiovascular disease (2017)
Australia–New Zealand
●Australian Cardiovascular Health and Rehabilitation Association (ACRA) and Cardiac Society of Australia and New Zealand (CSANZ): Position statement on cardiac rehabilitation – Face-to-face and telehealth delivery options (2020)
●National Heart Foundation of Australia (NHFA) and CSANZ: Australian clinical guidelines for the management of acute coronary syndromes (2016)
●NHFA and CSANZ: Reducing risk in heart disease − An expert guide to clinical practice for secondary prevention of coronary heart disease (2012)
●National Vascular Disease Prevention Alliance (NVDPA): Guidelines for the management of absolute cardiovascular disease risk (2012)
Japan
●[In English] Japanese Circulation Society (JCS)/Japanese Association of Cardiac Rehabilitation (JACR): 2021 guideline on rehabilitation in patients with cardiovascular disease (published 2023)
●[In Japanese] JCS/JACR: Guideline on rehabilitation in patients with cardiovascular disease (2021)
